Agnete B. Fredriksen

642 total citations
28 papers, 526 citations indexed

About

Agnete B. Fredriksen is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Agnete B. Fredriksen has authored 28 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Agnete B. Fredriksen's work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Agnete B. Fredriksen is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (14 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Agnete B. Fredriksen collaborates with scholars based in Norway, United States and Germany. Agnete B. Fredriksen's co-authors include Bjarne Bogen, Gunnveig Grødeland, Inger Sandlie, Karoline W. Schjetne, Siri Mjaaland, Pier Adelchi Ruffini, Kenneth H. Roux, Gro Tunheim, Keith M. Thompson and Geir Åge Løset and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Agnete B. Fredriksen

27 papers receiving 505 citations

Peers

Agnete B. Fredriksen

IMMUN

MB

EPIDE

RNMI

ONCOL

Ryan Tassone United States

Faı̈za Rharbaoui Germany

Gustáv Russ Slovakia

Daniel L. Levey United States

Melanie Wiesel Switzerland

Matt Ardito United States

Victor H. Van Cleave United States

Yotam Bar‐On Israel

Detlef Stober Germany

Peggy Farness United States

Ryan Tassone United States

Agnete B. Fredriksen

212 ×0.5

IMMUN

211 ×1.2

MB

98 ×0.7

EPIDE

128 ×1.3

RNMI

37 ×0.5

ONCOL

Citations per year, relative to Agnete B. Fredriksen Agnete B. Fredriksen (= 1×) peers Ryan Tassone

Countries citing papers authored by Agnete B. Fredriksen

Since Specialization

Citations

This map shows the geographic impact of Agnete B. Fredriksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnete B. Fredriksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnete B. Fredriksen more than expected).

Fields of papers citing papers by Agnete B. Fredriksen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnete B. Fredriksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnete B. Fredriksen. The network helps show where Agnete B. Fredriksen may publish in the future.

Co-authorship network of co-authors of Agnete B. Fredriksen

This figure shows the co-authorship network connecting the top 25 collaborators of Agnete B. Fredriksen. A scholar is included among the top collaborators of Agnete B. Fredriksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnete B. Fredriksen. Agnete B. Fredriksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ochsenreither, Sebastian, Geòrgia Anguera, Sebastian M. Dieter, et al.. (2025). Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.. Journal of Clinical Oncology. 43(16_suppl). 2639–2639.

2.

Norheim, Gunnstein, Monika Sekelja, Amine Namouchi, et al.. (2023). Antigen presenting cell targeted T cell DNA vaccine inducing strong and specific cellular responses across multiple T cell epitopes of SARS-COV-2. The Journal of Immunology. 210(Supplement_1). 159.03–159.03. 1 indexed citations

3.

Hillemanns, Peter, Kristina Lindemann, Jean‐François Baurain, et al.. (2022). 2022-RA-447-ESGO Efficacy and safety of VB10.16, a therapeutic DNA vaccine specifically targeting antigen-cell presenting cells, in combination with atezolizumab in patients with advanced HPV16-positive cervical cancer: results from a pre-planned interim analysis. International Journal of Gynecological Cancer. 32. A12–A12. 1 indexed citations

4.

Hillemanns, Peter, Linn Woelber, Gerd Böhmer, et al.. (2022). A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial. Clinical Cancer Research. 28(22). 4885–4892. 31 indexed citations

5.

Sekelja, Monika, et al.. (2019). Abstract 5003: Vaccibody DNA vaccine platform VB10.NEO induces strong neo-antigen specific CD8+ T cell responses critical to cure established tumors in pre-clinical models. Cancer Research. 79(13_Supplement). 5003–5003. 5 indexed citations

6.

Müller, Elisabeth, et al.. (2019). Abstract 2256: Combination of neoantigen DNA plasmid vaccine VB10.NEO and NKTR-214, a CD122-biased immunostimulatory cytokine, induces strong neoantigen-specific T cell responses and sustained tumor regression in pre-clinical models. Cancer Research. 79(13_Supplement). 2256–2256. 1 indexed citations

7.

Sekelja, Monika, et al.. (2019). Abstract 5003: Vaccibody DNA vaccine platform VB10.NEO induces strong neo-antigen specific CD8+ T cell responses critical to cure established tumors in pre-clinical models. 5003–5003. 1 indexed citations

8.

Lambert, Laura, Ekaterina Kinnear, Jacqueline U. McDonald, et al.. (2016). DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease. Frontiers in Immunology. 7. 321–321. 14 indexed citations

9.

Øynebråten, Inger, Jorma Hinkula, Agnete B. Fredriksen, & Bjarne Bogen. (2014). Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3. PLoS ONE. 9(8). e104814–e104814. 15 indexed citations

10.

Grødeland, Gunnveig, Siri Mjaaland, Gro Tunheim, Agnete B. Fredriksen, & Bjarne Bogen. (2013). The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype. PLoS ONE. 8(11). e80008–e80008. 33 indexed citations

11.

Grødeland, Gunnveig, Siri Mjaaland, Kenneth H. Roux, Agnete B. Fredriksen, & Bjarne Bogen. (2013). DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza. The Journal of Immunology. 191(6). 3221–3231. 47 indexed citations

12.

Fredriksen, Agnete B., Inger Sandlie, & Bjarne Bogen. (2012). Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. SHILAP Revista de lepidopterología. 2. 154–154. 20 indexed citations

13.

Ruffini, Pier Adelchi, et al.. (2011). Targeted idiotype‐fusion DNA vaccines for human multiple myeloma: preclinical testing. European Journal Of Haematology. 86(5). 385–395. 9 indexed citations

14.

Ruffini, Pier Adelchi, Gunnveig Grødeland, Agnete B. Fredriksen, & Bjarne Bogen. (2010). Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines. Vaccine. 29(2). 191–199. 28 indexed citations

15.

Vartdal, Frode, Agnete B. Fredriksen, K. M. Thompson, et al.. (2007). T Cells from Multiple Sclerosis Patients Recognize Multiple Epitopes on Self‐IgG. Scandinavian Journal of Immunology. 66(4). 393–401. 14 indexed citations

16.

Tunheim, Gro, Keith M. Thompson, Agnete B. Fredriksen, et al.. (2007). Human receptors of innate immunity (CD14, TLR2) are promising targets for novel recombinant immunoglobulin-based vaccine candidates. Vaccine. 25(24). 4723–4734. 9 indexed citations

17.

Fredriksen, Agnete B., Inger Sandlie, & Bjarne Bogen. (2006). DNA Vaccines Increase Immunogenicity of Idiotypic Tumor Antigen by Targeting Novel Fusion Proteins to Antigen-Presenting Cells. Molecular Therapy. 13(4). 776–785. 66 indexed citations

18.

Bogen, Bjarne, Pier Adelchi Ruffini, Alexandre Corthay, et al.. (2006). Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.. PubMed. 91(7). 941–8. 19 indexed citations

19.

Schjetne, Karoline W., et al.. (2005). Induction of central T cell tolerance: Recombinant antibodies deliver peptides for deletion of antigen-specific CD4+8+ thymocytes. European Journal of Immunology. 35(11). 3142–3152. 5 indexed citations

20.

Holmøy, Trygve, et al.. (2005). Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. European Journal of Immunology. 35(6). 1786–1794. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact